Fujifilm to sponsor keynote address by Nancy M. Cappello, PhD, policy
advocate and breast cancer survivor
STAMFORD, Conn.–(BUSINESS WIRE)–(Booth #145) – FUJIFILM
Medical Systems U.S.A., Inc., a leading provider of diagnostic
imaging products and medical informatics solutions, will take a lead
role at the National Consortium of Breast Centers (NCoBC) 2016
Conference by sponsoring the keynote presentation by Nancy M. Cappello,
PhD, Executive Director and Founder of the two nonprofits Are You Dense,
Inc, and Are You Dense Advocacy, Inc., on Saturday, April 9, 2016 from
8:30-9:15am in the Vendome Ballroom at the Paris Las Vegas. Fujifilm
will also showcase its Aspire Cristalle mammography system in Booth #145
at NCoBC from April 9-13, 2016.
“At Fujifilm, our goal is to support patient awareness, early detection
and patient centric care,” said Rob Fabrizio, director of marketing and
product development, Digital X-Ray and Women’s Health, FUJIFILM Medical
Systems U.S.A., Inc. “We’re proud to sponsor the keynote presentation at
NCoBC emphasizing the critical role of patient and provider awareness of
breast type and their corresponding risk factors in screening for breast
Dr. Cappello’s keynote remarks—“Why I Talk to Strangers About My
Breasts”—will focus on breast density ramifications and legislation. The
impact of dense breast tissue remained exclusively in the medical
journals for more than a decade until, in 2009, through Dr. Cappello’s
relentless activism, Connecticut, her home state, became the first state
to mandate the reporting of dense breast tissue to the patient through
the mammography report. From patient to advocate, Dr. Cappello launched
Are You Dense, Inc. and Are You Dense Advocacy, Inc., both work together
as a global grassroots density education and reporting movement. Her
inspiring story, conveyed with passion and humor, illustrates how one
person can make a potential life-saving difference in women’s health.
Dr. Cappello will also be available at the Fujifilm booth #145 for
informal Q&A sessions on Saturday, April 9th from
10:15am-10:45am and 11:45am-1:00pm.
“It is my personal priority—and the mission of my organizations— to
ensure that patients, policymakers and health-care providers understand
the significance of dense breast tissue and the importance of regular,
reliable screening,” said Dr. Cappello. “I am very grateful to have the
support of Fujifilm, a company that clearly understands how educational
efforts and awareness-building can help save lives.”
Fujifilm’s Aspire Cristalle mammography system features an innovative
hexagonal close pattern (HCP) detector design, engineered for higher
acquisition efficiency, to enhance detail for improved low dose
performance. The result is sharper images with gentler dose to the
patient. Additionally, Aspire Cristalle incorporates a patient calming
design and Fujifilm’s patented Comfort Paddle which is designed to make
the most physically unpleasant part of mammograms, noticeably more
comfortable for the patient.
In November 2015, Fujifilm submitted to the U.S. Food and Drug
Administration (FDA) the second module of its premarket approval (PMA)
application for Digital Breast Tomosynthesis (DBT)*, as an optional
upgrade for the Aspire Cristalle mammography system.
*Caution: Investigational Device. Limited by U.S. Federal Law to
Investigational Use. The information about this product is preliminary.
The product is under development and not commercially available in the
United States and its future availability cannot be ensured.
For more information, please visit www.fujifilmhealthcare.com.
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of
diagnostic imaging products and medical informatics solutions to meet
the needs of healthcare facilities today and well into the future. From
an unrivaled selection of digital x-ray systems, to the Synapse® brand
of PACS, RIS and cardiovascular products, to advanced women’s health
imaging systems, Fujifilm has products that are ideal for any size
imaging environment. The Endoscopy Division of FUJIFILM Medical Systems
U.S.A., Inc. supplies high quality, technologically advanced FUJINON
brand endoscopes to the medical market. The TeraMedica Division delivers
healthcare informatics, and is the leading provider of vendor neutral,
enterprise-wide solutions for unrestricted medical image management.
FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT.
For more information please visit www.fujifilmhealthcare.com and
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation
and leading-edge products to a broad spectrum of industries, including:
healthcare, with medical systems, pharmaceuticals and cosmetics; graphic
systems; highly functional materials, such as flat panel display
materials; optical devices, such as broadcast and cinema lenses; digital
imaging; and document products. These are based on a vast portfolio of
chemical, mechanical, optical, electronic, software and production
technologies. In the year ended March 31, 2015, the company had global
revenues of $20.8 billion, at an exchange rate of 120 yen to the dollar.
Fujifilm is committed to environmental stewardship and good corporate
citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their
Lauren Geloso, 914-789-8303